Artículos del autor

solaci

Day 2

Possible benefit for patients with acute myocardial infarction but without ventricular dysfunction.

Background: To evaluate whether the administration of eplerenone 24 hours after an acute myocardial infarction (AMI) in...
solaci -
Day 2

Possible benefit for patients with acute myocardial infarction but without ventricular dysfunction.

Background: To evaluate whether the administration of eplerenone 24 hours after an acute myocardial infarction (AMI) in...
solaci -
Day 3

MASS COMM: Elective angioplasty can be performed in hospital with or without emergency surgical support.

Increasingly, the frequent performances of elective angioplasties are in hospitals that do not have a cardiac surgery...
solaci -
Day 3

CABG off-pump, same results at one year-pump surgery.

The relative benefits and risks of off-pump coronary artery bypass grafting (CABG) as compared with the use...
solaci -
Day 3

GOPCABE: similar results for in-pump or off-pump surgery in elderly patients

Background: There is much debate about a possible benefit of coronary artery bypass grafting (CABG) without cardiopulmonary...
solaci -
Day 1

TCT Session. An assessment of the severity of lesions. A debate about the different methods to assess coronary physiology.

FFR is the gold standard (Dr. William Fearon) Dr. William reported on the benefits of using FFR:  • A...
solaci -
Day 2

PRATO ACS: Rosuvastatin reduces the incidence of contrast nephropathy in patients with acute coronary syndrome who receive early invasive strategy

The aim of this study was to determine whether patients without ST-segment elevation acute coronary syndromes who...
solaci -
Day 2

NEXT trial looked at a non-inferiority degradable polymer stent versus a second-generation permanent polymer stent.

Previous studies of non-inferiority (SORT-OUT III and V) compared the biodegradable polymer biolimus-eluting stent (BES) with permanent...
solaci -